Statistics for Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future.

Total visits

views
Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future. 445

Total visits per month

views
March 2024 0
April 2024 1
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0

File Visits

views
Grabowski_Guha_Salgado_Health Affairs_ June 2014.pdf 636

Top country views

views
United Kingdom 293
United States 32
Germany 28
China 6
Denmark 3
India 3
Singapore 3
France 2
South Korea 2
Canada 1
Switzerland 1
Egypt 1
Italy 1

Top city views

views
Alexandria 201
Kiez 16
Ballerup 3
Changi 3
Guntur 3
New York 3
Washington 3
Durham 2
Philadelphia 2
Seattle 2
Seoul 2
Woodbridge 2
Alpharetta 1
Arlington 1
Bedford 1
Boardman 1
Boston 1
Bronx 1
Brooklyn 1
Dalian 1
Maggia 1
Mount Laurel 1
Mountain View 1
Overland Park 1
Sainte-thérèse 1
Staatsburg 1
Suzhou 1
Union 1
Wilmington 1
Yulee 1